In concert with TTS and WHO, IXA has the mission to promote ethical and regulatory guidelines for xenotransplantation clinical trials for consideration by national regulatory authorities. IXA has three important goals:
- To facilitate implementation of internationally consistent national regulations for the conduct of xenotransplant clinical trials.
- To promote conduct of ethical clinical trials that are safe for the participants, minimize health risks for the public at large, and are likely to promote future success.
- To educate people around the world about the benefits, risks, and scientific hurdles to achieving the vast therapeutic potential of cross-species transplantation.
Please follow this link for recommendations issued by IXA working groups and other international entities.